13058_2020_1245_MOESM3_ESM.pdf (9.21 MB)
MOESM3 of p66ShcA functions as a contextual promoter of breast cancer metastasis
journal contribution
posted on 2020-01-16, 04:56 authored by Kyle Lewis, Alex Kiepas, Jesse Hudson, Julien Senecal, Jacqueline Ha, Elena Voorand, Matthew Annis, Valerie Sabourin, Ryuhjin Ahn, Rachel Selva, Sébastien Tabariès, Brian Hsu, Matthew Siegel, Matthew Dankner, Eduardo Canedo, Mathieu Lajoie, Ian Watson, Claire Brown, Peter Siegel, Josie Ursini-SiegelAdditional file 3: Figure S3. p66ShcA is phosphorylated on Ser36 in 4T1-537 breast cancer cells. (A) Immunoblot analysis of whole cell lysates isolated from 4T1-537 p66-CR (VC), p66-CR (WT) and p66-CR (S36A) breast cancer cells treated with PBS, 1 mM phenformin (2 h) or 20 μM sodium arsenite (4 h) using pSer-p66ShcA, ShcA- and Tubulin-specific antibodies. (B) DCFDA flow cytometric staining demonstrating ROS production in response to phenformin or sodium arsenite treatment.
